SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending as investors digest a massive fiscal fourth-quarter revenue beat and a significant expansion in its contracted backlog, with the community actively debating whether the company has successfully transitioned into a scaled, self-funding cash-flow machine. While bulls are highlighting the execution speed and strong AI infrastructure demand, some market participants remain cautious, focusing on the company's net losses, high share-based compensation, and the broader macro headwinds weighing on the sector.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is facing significant market volatility as investors weigh the company's defense against FDA briefing documents that challenge the validity of its statistical analysis methods. The community is sharply divided, with bulls pointing to the company's rebuttal regarding outdated documents and unmet patient needs, while skeptics emphasize the agency's criticism of protocol modifications and trial design.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is seeing significant community discussion driven by optimism surrounding the potential passage of the Clarity Act and its implications for institutional adoption. While some investors are focused on long-term utility and accumulation, others are debating the impact of market manipulation, regulatory uncertainty, and the asset's historical performance relative to other major cryptocurrencies.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is facing significant selling pressure as investors scrutinize the company's involvement in large-scale financing deals for AI infrastructure, with the community actively debating whether these arrangements signal long-term AI demand or unsustainable balance sheet risk. Traders are closely watching critical support levels as broader semiconductor sentiment cools, leading to a polarized discussion between those viewing the decline as a major buying opportunity and those fearing a deeper market correction.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

AMKOR Technology is trending as investors digest record second-quarter earnings and a solid, though slightly mixed, outlook that highlights the critical role of advanced packaging in the AI semiconductor supply chain. Community discussion centers on AMKOR's long-term potential as a key U.S.-based partner for industry giants like TSMC and NVIDIA, with many bullish on its multi-year expansion efforts despite recent share price volatility.

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP. Its platforms include Optogenetics, Transcriptnomics, and STARmap. The company was founded by Christopher A. Kroeger, Karl Deisseroth, Robert Malenka, and Karoly Nikolich in November 2018 and is headquartered in Redwood City, CA.

MapLight Therapeutics Inc.

MapLight Therapeutics is seeing significant volatility after reporting mixed clinical trial results for its schizophrenia treatment, which included a miss on the once-daily dosing arm. The community is sharply divided, with some investors debating if the steep selloff represents an oversold buying opportunity supported by the company's cash position, while others remain cautious about the long-term outlook for biotech firms following negative trial data.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is surging following a blockbuster earnings report that featured a revenue and EPS beat alongside guidance that signals accelerating AI infrastructure demand through 2027. Investors are actively debating the sustainability of current AI-driven margins, while sentiment remains overwhelmingly bullish as major hyperscalers continue their massive capital deployment programs.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The semiconductor sector is experiencing intense volatility as investors weigh robust corporate AI demand against concerns over crowded positioning, geopolitical risks, and high-stakes capital expenditure trends. Community sentiment remains polarized, with many traders debating whether this steep pullback marks a fundamental shift or a temporary reset within a long-term infrastructure cycle.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is seeing increased investor scrutiny as it navigates the transition period following the sunset of its temporary reimbursement payments. The community remains focused on the company's ability to drive standard-of-care adoption for its flagship dialysis infection-prevention product while monitoring potential legislative developments like the Kidney Care Access Protection Act.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as investors weigh significant volatility in the KOSPI market against heightened anticipation for major mega-cap tech earnings and Federal Reserve policy decisions. Community discussion is sharply divided, with participants actively debating whether recent semiconductor weakness represents a structural correction or a buying opportunity amidst broader macroeconomic uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

USANA Health Sciences Renews Four-Year Partnership with Nordiq Canada, Deepening Commitment to Clean Sport and Elite Athlete Nutrition

USANA Health Sciences Renews Four-Year Partnership with Nordiq Canada, Deepening Commitment to Clean Sport and Elite Athlete Nutrition USANA Health Sciences Renews Four-Year Partnership with Nordiq Canada, Deepening Commitment to Clean Sport and Elite Athlete Nutrition PR Newswire SALT LAKE CITY...

USANA Schedules Second Quarter 2026 Earnings Release and Conference Call

USANA Health Sciences, Inc. (NYSE:USNA) today announced that second quarter 2026 results will be released after the close of market on Tuesday, August 4, 2026. Shortly following the issuance of the Companys earnings release, the Company will post its Management Commentary document on the Companys...

Kevin Guest: World Cup Determination Shows the Power of Grit, Preparation, Persistence

Kevin Guest: World Cup Determination Shows the Power of Grit, Preparation, Persistence Kevin Guest: World Cup Determination Shows the Power of Grit, Preparation, Persistence PR Newswire SALT LAKE CITY, July 1, 2026 SALT LAKE CITY, July 1, 2026 /PRNewswire/ -- As World Cup soccer players push...

5 Low P/B Stocks That Investors Can Add to Their Portfolio in July

PAGS, USNA, GM, NEXA and AVT stand out after passing low price-to-book value screens, highlighting five stocks that merit a closer look in July.

Should Value Investors Buy USANA Health Sciences (USNA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

4 Value Stocks to Buy as Lower Energy Costs Strengthen Market Outlook

Nexa Resources, Avnet, StoneCo and USANA Health stand out as lower oil prices ease inflation worries and boost the case for value stocks.

USANA Celebrates 10 Years of Making the World a Better Place During World Service Week

USANA Celebrates 10 Years of Making the World a Better Place During World Service Week USANA Celebrates 10 Years of Making the World a Better Place During World Service Week PR Newswire SALT LAKE CITY, June 16, 2026 SALT LAKE CITY, June 16, 2026 /PRNewswire/ -- For the past 10 years, theUSANA...

Zacks.com featured highlights include StoneCo, USANA Health, Strategic Education, Nexa Resources and CVS

STNE, USNA, STRA, NEXA and CVS are highlighted as low price-to-book stocks with solid growth projections and strong value scores.

5 Low Price-to-Book Stocks That Are Worth Buying in June

STNE, USNA, STRA, NEXA and CVS passed a low price-to-book screen, combining discounted valuations with projected long-term EPS growth.

These 4 Low Price-to-Cash Flow Stocks Have Winning Potential

Nexa Resources leads a screen of four low P/CF value stocks, with consensus sales and EPS growth forecasts and wildly mixed 12-month returns.

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.

Usana Health Sciences Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

The Fed's July 28-29 meeting has markets debating a hold versus a hike, not a cut, with CME FedWatch pricing roughly a 65% chance of no change and rising odds of a September rate increase amid inflation running well above the 2% target. What do you expect the Fed to decide? Drop a comment with when you expect the first cut/hike to be.

What do you expect the Fed to decide at its FOMC meeting?  
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$22.34
Prev Close	$21.32
Open	$21.44
Dividend Yield	0.00%
50-Day Moving Average	$19.97
Beta	0.96
Avg. Volume	122,475.14
PE Ratio	46.99

52-Week High	$32.32
52-Week Low	$16.60
Market Capitalization	$393.63M
EPS (Annual)	$0.5793
Price to Book	0.76
Revenue Per Employee	$589,335.67

Feed

News

Sentiment

Earnings

Fundamentals

Info

USNAUsana Health Sciences Inc

Latest USNA News